Current treatments for cognitive symptoms in patients with diagnoses such as schizophrenia are inadequate. We need to ...

For numerous individuals with schizophrenia, living with the condition involves challenges, not only related to hallucinations or delusions, but also due to subtler difficulties, such as problems ...

CT-155 is a smartphone app that integrates psychosocial interventions delivered using an adaptive goal-setting technique. A phase 3 trial has demonstrated that it can reduce the negative symptoms of ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...

A free community lecture by a national expert on schizophrenia treatment will be held from 8 a.m. to noon on Dec. 10 at Peak Vista Community Health Centers, 2828 International Circle, Suite 120, in ...

The agency also considered Uzedy's tolerability, efficacy and extended safety data in schizophrenia treatment, substantiated by the pivotal Phase III RISE and SHINE studies. Uzedy received FDA ...

The invisible friends Cat Price talked about in childhood were chalked up to an active imagination, and her adolescent angst and hostility got interpreted as teenage rebellion. When, as a high school ...

Schizophrenia is a serious and often misunderstood mental illness that affects how a person thinks, feels, and behaves. It involves a combination of symptoms, including hallucinations, delusions, ...

Panelists discuss how schizophrenia presents a wide spectrum of symptoms categorized into positive, negative, and cognitive ...

Panelists discuss how schizophrenia imposes significant economic costs across direct medical expenses, nonmedical expenses, and indirect costs, with negative symptoms particularly amplifying the ...